Gapping down
Other news:
- DBVT -15.6% (secures agreement with FDA on safety exposure data required for BLA for Viaskin Peanut Patch in 4--7-year-olds)
- JHX -11.2% (AZEK and James Hardie (JHX) to merge creating a leading building products growth platform; both co's reaffirm guidance)
- GMAB -3.2% (AbbVie (ABBV) files complaint against Genmab in the U.S. District Court for the Western District of Washington; Genmab refutes allegations and will vigorously defend the company)
- GFI -2.3% (makes offer to buy Gold Road Resources, but the proposal has been rejected)
- SARO -2.1% (announces that two of its stockholders, affiliates of The Carlyle Group Inc. and GIC Private Limited, intend to offer for sale in an underwritten secondary offering an aggregate of 30,000,000 shares of the Company's common stock)
- HROW -1.2% (announces that the Centers for Medicare & Medicaid Services has approved Harrow's transitional pass-through application for TRIESENCE 40 mg/mL)
- TECH -1% (to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting)